These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 36569931)

  • 1. How GRAIL controls Treg function to maintain self-tolerance.
    Fathman CG; Yip L; Gómez-Martín D; Yu M; Seroogy CM; Hurt CR; Lin JT; Jenks JA; Nadeau KC; Soares L
    Front Immunol; 2022; 13():1046631. PubMed ID: 36569931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Common Druggable Defect in Regulatory T Cells from Patients with Autoimmunity.
    Soares L; Yip L; Hurt CR; Fathman G
    Crit Rev Immunol; 2020; 40(3):185-193. PubMed ID: 33389883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose IL-2 therapy in autoimmune diseases: An update review.
    Zhang R; Zhao Y; Chen X; Zhuang Z; Li X; Shen E
    Int Rev Immunol; 2024 May; 43(3):113-137. PubMed ID: 37882232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T Regulatory Cells From Non-obese Diabetic Mice Show Low Responsiveness to IL-2 Stimulation and Exhibit Differential Expression of Anergy-Related and Ubiquitination Factors.
    Godoy GJ; Olivera C; Paira DA; Salazar FC; Ana Y; Stempin CC; Motrich RD; Rivero VE
    Front Immunol; 2019; 10():2665. PubMed ID: 31824482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PP2A enables IL-2 signaling by preserving IL-2Rβ chain expression during Treg development.
    Sharabi A; Li H; Kasper IR; Pan W; Meidan E; Tsokos MG; Moulton VR; Tsokos GC
    JCI Insight; 2019 Mar; 5(9):. PubMed ID: 30912768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells.
    Kumar P; Saini S; Khan S; Surendra Lele S; Prabhakar BS
    Cell Immunol; 2019 May; 339():41-49. PubMed ID: 30482489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naive CD4 t cell proliferation is controlled by mammalian target of rapamycin regulation of GRAIL expression.
    Lin JT; Lineberry NB; Kattah MG; Su LL; Utz PJ; Fathman CG; Wu L
    J Immunol; 2009 May; 182(10):5919-28. PubMed ID: 19414743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of IL-12 on Tregs and non-Treg T cells: roles of IFN-γ, IL-2 and IL-2R.
    Zhao J; Zhao J; Perlman S
    PLoS One; 2012; 7(9):e46241. PubMed ID: 23029447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treg Enhancing Therapies to Treat Autoimmune Diseases.
    Eggenhuizen PJ; Ng BH; Ooi JD
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Lipopolysaccharide-Induced Inflammation Lowers IL-2R Signaling and the Proliferative Potential of Regulatory T Cells.
    Hsiung S; Moro A; Ban Y; Chen X; Savio AS; Hernandez R; Malek TR
    Immunohorizons; 2020 Dec; 4(12):809-824. PubMed ID: 33334814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-2 as a therapeutic target for the restoration of Foxp3+ regulatory T cell function in organ-specific autoimmunity: implications in pathophysiology and translation to human disease.
    d'Hennezel E; Kornete M; Piccirillo CA
    J Transl Med; 2010 Nov; 8():113. PubMed ID: 21059266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulation Followed by Antigen-Specific T
    Cabello-Kindelan C; Mackey S; Sands A; Rodriguez J; Vazquez C; Pugliese A; Bayer AL
    Diabetes; 2020 Feb; 69(2):215-227. PubMed ID: 31712320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
    Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
    J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the Threshold IL-2 Signal Required for Induction of Selective Treg Cell Responses Using Engineered IL-2 Muteins.
    Ghelani A; Bates D; Conner K; Wu MZ; Lu J; Hu YL; Li CM; Chaudhry A; Sohn SJ
    Front Immunol; 2020; 11():1106. PubMed ID: 32582190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-Zone IL-2 Signaling: Fusion Proteins Containing Linked CD25 and IL-2 Domains Sustain Tolerogenic Vaccination
    DeOca KB; Moorman CD; Garcia BL; Mannie MD
    Front Immunol; 2020; 11():541619. PubMed ID: 33072087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splicing factor SRSF1 controls autoimmune-related molecular pathways in regulatory T cells distinct from FoxP3.
    Cassidy MF; Herbert ZT; Moulton VR
    Mol Immunol; 2022 Dec; 152():140-152. PubMed ID: 36368121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple autoimmune-associated variants confer decreased IL-2R signaling in CD4+ CD25(hi) T cells of type 1 diabetic and multiple sclerosis patients.
    Cerosaletti K; Schneider A; Schwedhelm K; Frank I; Tatum M; Wei S; Whalen E; Greenbaum C; Kita M; Buckner J; Long SA
    PLoS One; 2013; 8(12):e83811. PubMed ID: 24376757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-2R signaling is essential for functional maturation of regulatory T cells during thymic development.
    Cheng G; Yu A; Dee MJ; Malek TR
    J Immunol; 2013 Feb; 190(4):1567-75. PubMed ID: 23315074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treg Therapies Revisited: Tolerance Beyond Deletion.
    Pilat N; Sprent J
    Front Immunol; 2020; 11():622810. PubMed ID: 33633742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD25 and Protein Phosphatase 2A Cooperate to Enhance IL-2R Signaling in Human Regulatory T Cells.
    Ding Y; Yu A; Tsokos GC; Malek TR
    J Immunol; 2019 Jul; 203(1):93-104. PubMed ID: 31085588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.